Clinical significance of von Willebrand factor in patients with adult dermatomyositis

Clinical Rheumatology

Volumn 24, Issue 4, 2005, Pages 352-357

  Komiya, Toshiyuki ^a   Negoro, Nobuo ^b   Kondo, Kyoko ^b   Miura, Katsuyuki ^b   Hirota, Yoshio ^b   Yoshikawa, Junichi ^b  

^a Kitano Hospital   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adult dermatomyositis; Endothelial injury; von Willebrand factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE; LACTATE DEHYDROGENASE; MUSCLE ENZYME; PREDNISOLONE; VON WILLEBRAND FACTOR;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; DRUG EFFICACY; ENDOTHELIUM INJURY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FEMALE; FEVER; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MALE; MULTIVARIATE ANALYSIS OF COVARIANCE; MUSCLE WEAKNESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DERMATOMYOSITIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; VON WILLEBRAND FACTOR;

EID: 23344438687     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-1027-z     Document Type: Article

References (36)

1. Callen JP (2000) Dermatomyositis. Lancet 355:53-57 10.1016/ S0140-6736(99)05157-0
2. Nawata Y, Kurasawa K, Takabayashi K et al (1999) Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J Rheumatol 26:1527-1533 1:CAS:528:DyaK1MXksFemtLY%3D
3. Douglas WW, Tazelaar HD, Hartman TE et al (2001) Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 164:1182-1185 1:STN:280:DC%2BD3Mrms1OhtQ%3D%3D
4. Hill CL, Zhang Y, Sigurgeirsson B et al (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study. Lancet 357:96-100 10.1016/S0140-6736(00)03540-6
5. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344-347 1:STN:280:CSqC3MfovVI%3D
6. Dalakas MC (1995) Immunopathogenesis of inflammatory myopathies. Ann Neurol 37 [Suppl 1]:S74-S86 8968219
7. Arahata K, Engel AG (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 16:193-208 1:STN:280:BiuA3crntlc%3D
8. Carpenter S, Karpati G (1981) The major inflammatory myopathies of unknown cause. Pathol Annu 16:205-237 1:STN:280:Bi2C38nkvFc%3D
9. Kissel JT, Mendell JR, Rammohan KW (1986) Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 314:329-334 1:STN:280:BimC3Mflt1M%3D
10. De Visser M, Emslie-Smith AM, Engel AG (1989) Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle. J Neurol Sci 94:181-192 10.1016/ 0022-510X(89)90228-1
11. Emslie-Smith AM, Engel AG (1990) Microvascular changes in early and advanced dermatomyositis: A quantitative study. Ann Neurol 27:343-356 1:STN:280:By%2BB1c3ktlQ%3D
12. Ruggeri ZM, Ware J (1992) The structure and function of von Willebrand factor. Thromb Haemost 67:594-599 1:CAS:528:DyaK38XkvVGgsbg%3D
13. Bowie EJ, Solberg LA, Jr., Fass DN et al (1986) Transplantation of normal bone marrow into a pig with severe von Willebrand's disease. J Clin Invest 78:26-30 1:STN:280:BimB2M7jtVw%3D
14. Hamilton KK, Sims PJ (1987) Changes in cytosolic Ca2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine. Study of microcarrier cell monolayers using the fluorescent probe indo-1. J Clin Invest 79:600-608 1:CAS:528:DyaL2sXhtlaiurw%3D
15. Ribes JA, Francis CW, Wagner DD (1987) Fibrin induces release of von Willebrand factor from endothelial cells. J Clin Invest 79:117-123 1:CAS:528:DyaL2sXot1Cqtw%3D%3D
16. Woolf AD, Wakerley G, Wallington TB, Scott DG, Dieppe PA (1987) Factor VIII related antigen in the assessment of vasculitis. Ann Rheum Dis 46:441-447 1:STN:280:BiiA38rht1c%3D
17. Greaves M, Malia RG, Milford Ward A et al (1988) Elevated von Willebrand factor antigen in systemic sclerosis: Relationship to visceral disease. Br J Rheumatol 27:281-285 1:STN:280:BieA3M%2FgtFU%3D
18. Kayal S, Jais JP, Aguini N, Chaudiere J, Labrousse J (1998) Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 157:776-784 1:STN:280:DyaK1c7ns1OltQ%3D%3D
19. Jacobson SH, Egberg N, Hylander B, Lundahl J (2002) Correlation between soluble markers of endothelial dysfunction in patients with renal failure. Am J Nephrol 22:42-47 10.1159/000046673
20. Kida S (1990) Studies on von Willebrand factor antigen in endothelial cells and sera of patients with connective tissue diseases. Ryumachi 30:17-25 1:STN:280:By%2BA3szjtlc%3D
21. Salojin KV, Bordron A, Nassonov EL, et al (1997) Anti-endothelial cell antibody, thrombomodulin, and von Willebrand factor in idiopathic inflammatory myopathies. Clin Diagn Lab Immunol 4:519-521 1:STN:280:ByiH2crptFQ%3D
22. Guzman J, Petty RE, Malleson PN (1994) Monitoring disease activity in juvenile dermatomyositis: The role of von Willebrand factor and muscle enzymes. J Rheumatol 21:739-743 1:STN:280:ByuA3cbgsVA%3D
23. Bloom BJ, Tucker LB, Miller LC, Schaller JG (1995) von Willebrand factor in juvenile dermatomyositis. J Rheumatol 22:320-325 1:STN:280:ByqB2MjjtVY%3D
24. Tanimoto K, Nakano K, Kano S et al (1995) Classification criteria for polymyositis and dermatomyositis. J Rheumatol 22:668-674 1:STN:280:ByqA3M7isFI%3D
25. HJ Hislop J Montgomery 1995 Muscle testing 6th edn WB Saunders Philadelphia
26. Shima M, Fujimura Y, Nishiyama T et al (1995) ABO blood group genotype and plasma von Willebrand factor in normal individuals. Vox Sang 68:236-240 1:CAS:528:DyaK2MXms1Srsr4%3D
27. Son K, Tomita Y, Shimizu T et al (2000) Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis. Intern Med 39:128-135 1:STN:280:DC%2BD3c7psV2ltQ%3D%3D
28. Conlan MG, Folsom AR, Finch A et al (1993) Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 70:380-385 1:STN:280:ByuD1c3jtFc%3D
29. Estruch R, Grau JM, Fernandez-Sola J et al (1992) Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy. Hum Pathol 23:888-895 10.1016/0046-8177(92)90400-W
30. Hattori R, Hamilton KK, McEver RP, Sims PJ (1989) Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 264:9053-9060 1:CAS:528:DyaL1MXktVGmurk%3D
31. Mader R, Keystone EC (1993) Inflammatory myopathy - do we have adequate measures of the treatment response? J Rheumatol 20:1105-1107 1:STN:280:ByyA1c7mtFY%3D
32. Rider LG (1996) Assessment of disease activity and its sequelae in children and adults with myositis. Curr Opin Rheumatol 8:495-506 1:STN:280:ByiC2s7hvFM%3D
33. Kagen LJ, Aram S (1987) Creatine kinase activity inhibitor in sera from patients with muscle disease. Arthritis Rheum 30:213-217 1:CAS:528:DyaL2sXhslCjtbw%3D
34. Bohlmeyer TJ, Wu AH, Perryman MB (1994) Evaluation of laboratory tests as a guide to diagnosis and therapy of myositis. Rheum Dis Clin North Am 20:845-856 1:STN:280:ByqC2MflvFw%3D
35. Frijns R, Fijnheer R, Schiel A et al (2001) Persistent increase in plasma thrombomodulin in patients with a history of lupus nephritis: endothelial cell activation markers. J Rheumatol 28:514-519 1:CAS:528:DC%2BD3MXisVyqurk%3D
36. Plotz PH, Dalakas M, Leff RL et al (1989) Current concepts in the idiopathic inflammatory myopathies: Polymyositis, dermatomyositis, and related disorders. Ann Intern Med 111:143-157 1:STN:280:BiaA3c7jt1E%3D